IPAD-DB ID | S00184 |
Name | DHA |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 7 H 1 0 O 8 |
Molecular Weight | 222.15g/mol |
IUPAC Name | (4R, 5R, 6S)-2, 4, 5-trihydroxyoxane-2, 6-dicarboxylic acid |
InChI | InChI=1S/C7H10O8/c8-2-1-7(14, 6(12)13)15-4(3(2)9)5(10)11/h2-4, 8-9, 14H, 1H2, (H, 10, 11)(H, 12, 13)/t2-, 3-, 4+, 7?/m1/s1 |
InChIKey | ZJDMTWUYUXJUEE-BMJXUZCVSA-N |
Canonical SMILES | C1C(C(C(OC1(C(=O)O)O)C(=O)O)O)O |
PubChem CID | 15608515 |
DrugBank Accession Number | - |
CAS Registry Number | - |
Molecular Weight(Computed by SwissADME) | 222.15 |
Hac(Computed by SwissADME) | 15 |
Volume(Computed by ADMETlab 2.0) | 186.121 |
Density(Computed by ADMETlab 2.0) | 1.193 |
nRing(Computed by ADMETlab 2.0) | 1 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 8 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 8 |
Flexibility(Computed by ADMETlab 2.0) | 0.25 |
Stero Centers(Computed by ADMETlab 2.0) | 4 |
LogS(Computed by ADMETlab 2.0) | -0.833 |
LogD(Computed by ADMETlab 2.0) | -0.704 |
logP(Computed by ADMETlab 2.0) | -1.645 |
TPSA(Computed by SwissADME) | 144.52 |
Hbond Acceptor(Computed by SwissADME) | 8 |
Hbond Donor(Computed by SwissADME) | 5 |
Rotatable Bonds(Computed by SwissADME) | 2 |
GI Absorption(Computed by SwissADME) | Low |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -9.06 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 1 |
Veber(Computed by SwissADME) | 1 |
Egan(Computed by SwissADME) | 1 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.56 |